Robert Hettle
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
- Economics and Econometrics top 5%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
Papers in
- Oncology 21
- PARP inhibition in cancer therapy 19
-
- Health Systems, Economic Evaluations, Quality of Life 20
- Co-authors
- Robert M. Hodgson (1 shared paper)Stephen Palmer (1 shared paper)Nerys F. Woolacott (1 shared paper)Julie S. Jones-Diette (1 shared paper)Mark Stephen Corbett (1 shared paper)Seb Hinde (1 shared paper)Mohd Kashif Siddiqui (2 shared papers)Lara J. Wolfson (2 shared papers)
- Journals
- Value in Health (11 papers)Annals of Oncology (5 papers)Journal of Medical Economics (3 papers)Gynecologic Oncology (3 papers)Current Medical Research and Opinion (2 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Robert Hettle
54 papers receiving 648 citations
Peers
Comparison fields: 5 of 48
- Oncology 202
- Economics and Econometrics 208
- Pathology and Forensic Medicine 100
- Infectious Diseases 66
- Reproductive Medicine 34
Countries citing papers authored by Robert Hettle
This map shows the geographic impact of Robert Hettle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hettle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hettle more than expected).
Fields of papers citing papers by Robert Hettle
This network shows the impact of papers produced by Robert Hettle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hettle. The network helps show where Robert Hettle may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Hettle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 110 | |
| 2 | 2017 | 70 | |
| 3 | 2019 | 70 | |
| 4 | 2021 | 46 | |
| 5 | 2015 | 43 | |
| 6 | 2018 | 34 | |
| 7 | 2021 | 25 | |
| 8 | 2012 | 22 | |
| 9 | 2021 | 22 | |
| 10 | 2017 | 20 | |
| 11 | 2020 | 17 | |
| 12 | 2011 | 14 | |
| 13 | 2017 | 12 | |
| 14 | 2023 | 11 | |
| 15 | 2015 | 10 | |
| 16 | 2020 | 10 | |
| 17 | 2021 | 10 | |
| 18 | 2021 | 9 | |
| 19 | 2023 | 9 | |
| 20 | 2015 | 8 |
About Robert Hettle
Robert Hettle is a scholar working on Oncology, Economics and Econometrics, Statistics and Probability, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 54 papers that have together received 668 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (20 papers), PARP inhibition in cancer therapy (19 papers), Statistical Methods in Clinical Trials (6 papers), Multiple Sclerosis Research Studies (6 papers), Tuberculosis Research and Epidemiology (4 papers), Advanced Breast Cancer Therapies (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Smoking Behavior and Cessation (2 papers). The work is most often cited by research in Oncology (202 citations), Economics and Econometrics (208 citations), Pathology and Forensic Medicine (100 citations), Infectious Diseases (66 citations) and Reproductive Medicine (34 citations). Robert Hettle has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Robert M. Hodgson, Stephen Palmer, Nerys F. Woolacott, Julie S. Jones-Diette, Mark Stephen Corbett, Seb Hinde, Mohd Kashif Siddiqui, Lara J. Wolfson, Xiaoyan Lu and Susan M. Domchek. Their work appears in journals such as Value in Health, Annals of Oncology, Journal of Medical Economics, Gynecologic Oncology and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.